Suggestions
Carl Nicholas Ng
GP @ Verge HealthTech Fund | Ex-Bain | HBS
Carl Nicholas Ng is a venture capitalist and Board Observer at Pathway Medical, a healthcare software company. Some key details about him include:
-
He is currently associated with Verge HealthTech Fund, where he likely works as an investor or partner.2
-
Carl has experience in the healthtech industry, having entered the sector in 2017.1
-
He holds an MBA from Harvard Business School, indicating a strong educational background in business.2
-
Based in Singapore, Carl has over 500 connections on LinkedIn, suggesting he is well-networked in his industry.2
-
As a Board Observer at Pathway Medical, he likely provides strategic insights and oversight to the company without holding a formal board position.3
-
Carl has shown interest in healthcare software that clinicians appreciate, as evidenced by his post about investing in Pathway.1
-
His LinkedIn username is carlnicholasng, matching the information provided in the query.12
Carl Nicholas Ng appears to be an experienced professional in the healthtech investment space, leveraging his education and industry knowledge to support and invest in promising healthcare technology companies like Pathway Medical.
Highlights
Capped off a quick trip to Singapore by taking out our interns from Nanyang Technological University Singapore for brunch. Thanks for the great work over the spring Ega Chang, and welcome to Verge HealthTech Fund for the summer Ying Xi Koh!
I had the privilege of writing a guest article for ImpactAlpha this week with my colleague Miguel Legarda. The article was prompted by something I heard at an impact investment conference last year:
"We’re still discussing if we should include healthcare under impact investing.”
At Verge HealthTech Fund, we believe the answer is an emphatic YES. In the article, we share our perspective as dedicated impact investors in healthcare technology:
📊 The continuing gap in impact funding for health vs. other impact priorities like climate and environment 🌐 The large and pressing global challenges in healthcare across developed and developing countries 💡 How healthtech can sustainably and effectively address these challenges, illustrated by reach52 ✅ Our framework for assessing impact in our investments, particularly in early-stage #deeptech startups
I hope we've been able to move the conversation around #impactinvesting in #healthcare forward, with our own particular focus on #healthttech and its potential for powerful, positive impact.
I'm grateful to our friends and supporters at #JnJImpactVentures, Caitlin Bristol, Dana Deardorff and Jordan Treible for providing us with the opportunity to make this argument to a wider audience.
Joseph Mocanu Scarlett Chen 陳思佳 Erki Mölder Edward Booty Jeremy Lim James Bair Rebecca Thomas Rowena Luk Rosana Rabines Daniel Armali Kenneth Gustavsen Arun Asok Kusi H. Divya Karan Investors for Health
